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Does the Ulceration of Mouse Skin Initiate Cancer? 
It is well known , says Samuel Cohen of the University of Ne-
brask a M edi cal Center, that ulceratin g the rat bladder initiates the 
sequen ce o f steps that lead to cancer, no t reversible later. And , 
in mouse skin , it is known th at if cancer is already initiated , 
ulcera tion acts as a promoter- it enables the already-initiated cells 
to become ca ncerous. So, Cohen and his co lleagues Ryohei H as-
egawa, M arga ret St. John , and T. Scott T ibbels asked, Can ul-
cera ti o n of mouse skin also initiate cancer? T hey report in this 
issue that it ca nnot. 
T he investigators wounded mouse skin and then applied a pro-
moter substance, 12-0 -tetradecanoylphorbol-13-acetate, or TPA. 
If ulce ration were a ca ncer initiato r, then the skin cells would 
becom e malignant foll owing the applica tion of TPA . "Our hy-
pothesis was that the cells would become cancerous," says Cohen. 
" We were surprised when they didn 't ." 
Cohen and his associates then asked why ulceration is an ini-
tiator in the bladder but not in the skin . They suggest that because 
skin proliferates so rapidly, it may have a well-developed repai r 
sys tem to repair molecular damage. Skin , Cohen proposes, may 
be " used to damage" and better able to deal with it. 
In addition, there are certain g rowth factors in urine, including 
epidermal growth factor and transferrin, that may act on the 
bladder cells so that they become initiated when they are wounded. 
In any event, Cohen says, the group concludes that "short-
term wounding by itselfis not capable ofleading to cancer. Some-
thing else is required. " 
Wound H ealing and the Role of Fibronectin 
In the pas t few years, it has become increasingly clear that flbro-
nectin may be crucial for epithelial cell binding, durin g morpho-
genesis and wound healing. But what was not known was whether 
kera tinocytes actuall y contribute fibronectin to the wound ma-
trix. 111. this issue, Edward O 'Keefe , David Woodley, Ronald Falk , 
W. R ay Gammon, and Robert Brigga man of the University of 
North Carolin a School of M edicine provide evidence that they 
do. 
Abo ut 5 yea rs ago, w hen flbronectin was first studied, inves-
tiga to r s thought that it was a fi broblast- but no t an epithelial 
cell-binding protein . Fibronectin was discovered because it caused 
fib ro blasts to attach to plas tic. But, resea rchers reported, fibro-
nectin did not enhance the attachment to or spread of epitheli al 
cells o n surfaces . 
So the idea gained credence that flbronectin is not particularly 
impo rtant to epithelial cells. B ut the pro blem with this hypoth-
esis, O 'Keefe explains, is that the researchers did no t study ke-
ratinocytes directl y. Instead, they studied cells from a malignant 
epithelial cell line and extrapolated their results to normal kerat-
inocy t es. A few yea rs ago, when O 'Keefe and o thers began look-
ing directl y at fl bronectin 's effects on keratinocytes, they found 
that flbronectin causes these cells to attach to surfaces and spread. 
The new studies showed that keratinocytes recognize fl bro-
nectin, spread on it, increase their m otility on it , and lay it down 
as they move. O'Keefe, Richard C lark of the National Jewish 
H ospital in D enver, and others also found that keratinocytes syn-
thesize and secrete fib ronectin . And investiga tors are reporting 
th at fibron ectin may be important in wound healing and in em-
bryogenesis. During embryogenesis, flbronectin " may direct ep-
ithelial o rgans to develop in the proper shape," O'Keefe says. 
O 'Keefe and his associates decided to use an in vitro skin equiv-
alent model to determine whether fibronectin is actually laid dow n 
by keratinocytes during wound healing. They found that not only 
is it laid down but " it's there pretty early. Fibronectin is there 
in abundance before the basement membrane is assembled," 
O'Keefe says. H e concludes that his findin gs are further evidence 
that flbron ectin may be involved in wound healing. Keratinocytes 
may use flbron ectin as a surface to migrate on and to cover the 
wound , he concludes. 
Understanding Ichthyosis Vulgaris 
About a yea r ago, Beverly Dale and Karen Holbrook of the 
University of Washing ton School of Medi cine biopsied affected 
skin fro m patients with ichthyosis vulgaris and reported that the 
keratinocytes have no detectable pro fi laggrin or fil aggrin . Now 
Philip FJeckm an, Dale, Holbrook , and Virginia Sybert continued 
their s tudies of the molecular genetics of ichth yosis vulga ris by 
examining cultured cells. They report their results in this issue. 
Although ichthyosis vulgaris is a relatively common inherited 
disease-occurrin g in as many as 1 in 250 to 300 individuals-it 
has n o t been entirely clear where the gene defec t lies. Since the 
University of Seattle group has been unusually successful in cul-
turing ditferentiated keratinocytes, they decided to look in vitro 
for evidence that the defect is in the fll aggrin gene. 
Profl laggrin and fil aggrin are produced in the granular layer of 
the epidermis. When purified fllaggrin is added to keratin fil a-
ments , large globules, keratohyaline granules, form . The hy-
pothesis is that fllaggrin is a matrix protein that acts as a scaffold 
for keratin fli aments to organize in the stratum corneum and form 
the keratin pattern. Then, more permanent bonds form and fil-
aggrin disappears from the matrix. 
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Patients w ith ichthyos is vul ga ris do not have the g ranu lar layer 
in their affected sk in. And although th eir un affected skin has a 
gran ular layer, it has sma ll er than no rm al amounts of profil aggrin 
and fi lagg rin , Fleck man reports . 
When Fleck man and hi s colleagues cultured keratin ocytes fro m 
normal volu nteers, the cells differen tiated , formed g ranules, and 
made profi lagg rin . But when they grew keratinocytes fro m pa-
tients with ichthyosis vulga ris, the cell s differentiated but were 
morph ologica ll y abno rmal. "They did no t have gra nules and did 
not make profi laggrin, " Fleckman says. M oreover, he reports, 
when they cultured cells from a ca rrier fo r ichthyos is vul garis 
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who was himself cl ini ca lly unaffected, the cel ls made only a smaU 
amount of pro fi laggrin . T hese cells, in vit ro, were interm ediate 
between no rm al cells and cells of clinica ll y affected patients. " In 
cu lture, the defect is unm asked," Fleckman says. 
N ow th at th ey have established thi s in vitro system , the g roup 
suggests that it ca n be used to stud y w hat profi laggrin and fi lag-
grin do and how the express ion of the pro fil aggrin gene is COI1-
trolled. Moreover, Fleckm an po ints o ut , ichthyosis vulgaris is 
onl y one o f a number o f skin diseases whose only manifesta tion 
is in the epidermis. It sho uld thus be possible to study these other 
epiderm al-specifi c diseases w ith cultured epidermal cells. 
D etermining Prognoses in Psoriasis 
A g roup of investiga to rs at Corn ell University M edica l College 
and Rockefeller Uni versity has evidence that mo lecul ar fea tu res 
of epiderm al cells can predict w heth er a pa tient with psoriasis has 
responded to treatment . T hey report their res ults in this issue. 
T he g roup , consistin g o f Lisa Sta iano-Coico, Alice Gottlieb, 
Lance Barazani, and D . Martin Ca rter measured the D NA and 
RN A content of ep iderma l cells fro m in volved and uninvo lved 
psoriatic skin and from no rm al skin. T hey also tested their epi-
derma l cell sa mples with a monocl onal antibody that indica tes 
that cells are basa l in nature. 
T hey fo und that the number of cycling epiderm al cells is in-
creased in involved and unin volved psoriatic skin . RNA levels, 
w hi ch meas ure protein synthesis, are also high in cells from in-
vo lved pso ri ati c skin , and the mo noclonal antibody marker in-
dicates th at Iesiona l skin has increased numbers of basa l cells. 
When patients with pso rias is are success fu ll y trea ted, the RNA 
levels of their epiderm al ceUs go down and the monoclonal an-
tibody stain in dica tes that there are fewer basa l cells. T he in ves-
tigators stress the impo rtan ce of lookin g at R NA levels because 
DNA levels remain eleva ted even thou gh patients respond to 
therapy . "Since it is m ainl y RNA that increases in psoriasis , dru gs 
that affect RNA metabolism mi ght be a way to treat the d isease," 
Gottlieb says. 
But the immediate cl ini cal appli ca tion of their work is to pro-
vide prognoses . T hey report in th eir paper on 10 patients. The 
RNA content of epiderm al cells of lesional skin remained rela-
tively low after treatm ent in 9 of them. T he tenth pa tient, how-
ever, although no t distin guishable fro m the others on the basis 
of clin ica l sig ns, had very high levels o f RN A in his epidermal 
cell s. He had a severe rel apse w ithin a month after cessa tion of 
therapy. 
T he D N A, RN A, and antibody tests must be done in an ac-
adem ic center, according to Gottli eb. B ut they are not technicaUy 
diffi cul t to perform and , Gott lieb says, "almost every medical 
school has the equipment to do th em ." Even tho ug h the rela-
tionship between RNA and active pso riasis remains to be deter-
mined, the tests may prove usefu l " to tell patients whether they 
ca n expect a prolonged remission ," Gottlieb says. 
